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Renal acidification. The renal acidification process regu-
lates acid-base balance by regulating the concentration of
plasma bicarbonate [1]. In normal man the renal acidifi-
cation process operates to maintain plasma bicarbonate at
physiologic concentrations. By way of accomplishing this,
the acidification process a) reclaims all filtered bicarbonate
and b) excretes an amount of acid equal to the amount of
nonvolatile acid produced endogenously, approximately
one mEq/kg of body weight per day in adults [2] and one
to two mEq/kg of body weight per day in infants and young
children [3]. Both reabsorption of bicarbonate and excretion
of acid appear to be mediated by a single operation of the
renal tubule: the exchange of reabsorbed Na+ for secreted
H.
At normal plasma bicarbonate concentrations and under
physiologic conditions the proximal tubule secretes H+
at a rate that reclaims 85 to 90% of filtered bicarbonate
[4, 5]. For each mole of secreted H+ exchanged with luminal
Na+, one mole of cellular HCO is generated and returned
to the blood. Secreted H used in the titration of luminal
HCO is not excreted in the urine as acid. Rather, the
H2C03 formed in the titration process dissociates to H20
and C02, which equilibrates with peritubular CO2. By
catalyzing this dissociation, carbonic anhydrase, located at
the luminal border of the proximal tubule, acts to reduce
the steady-state concentration of luminal H2C03 and there-
by to facilitate secretion of H [61. The acidification process
of the proximal tubule can be considered a high-capacity
(rate), low-gradient system [7], and accounts for the great
preponderance of H± secreted by the renal tubule.
In the distal nephron the H+ secretory process titrates
the remaining 10 to 15 % of filtered bicarbonate. The distal
H+ secretory process further titrates the major urinary
buffers, Na2HPO4 and NH to NaH2PO4 and NH, a
process that begins in the proximal nephron. "Titratable
acid" usually is largely a measure of H+ excreted as
NaH2PO4. In the collecting duct the secretory capacity for
H is small, but a large gradient (lumen-peritubular)
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generating ability [6] enables the kidney to reduce urinary
pH to values of five or less and to excrete ammonium and
titratable acid at a combined rate equal to that of the endo-
genous production of nonvolatile acid. The combined
excretion rates of titratable acid and NH minus the nor-
mally negligible excretion rate of bicarbonate is termed "net
acid excretion" [8]. Net acid excretion normally accounts
for no more than 3 % of renal H+ secretion at normal
plasma bicarbonate concentrations. When the rate of
excretion of bicarbonate exceeds that of the sum of titratable
acid and ammonium, "net base excretion" can be said to
occur.
Because the H4 secretory capacity of the distal nephron
appears to be small (relative to that of the proximal tu-
bule), relatively small changes in the amount of bicarbonate
delivered to the distal nephron can greatly alter urinary
pH and net acid (or net base) excretion. And because the
amount of bicarbonate delivered to the distal nephron is
determined by the amount of bicarbonate rejected by the
proximal tubule, the rate at which the proximal tubule
secretes H+ and the concentration of plasma bicarbonate
(filtered load of bicarbonate) are critical and complemen-
tary modulators of urinary pH and net acid (or net base)
excretion. The rate at which H+ is secreted by the proximal
tubule is increased by K+ depletion, increased arterial
Pco2 and extracellular volume depletion [7]. Conversely it
appears to be dampened by increased serum potassium con-
centration (without cellular depletion of potassium), reduced
arterial P02 and increased extracellular volume [7]. The
rate at which the distal nephron secretes H+ can be increased
by increasing intraluminal negativity (with respect to the
peritubular blood) such as by maneuvers that increase
the luminal concentration of poorly-reabsorbed anions
during states of enhanced distal tubular Na4 reabsorption
(i.e.) Na depletion or the administration of mineralocorti-
coids [9]). Aldosterone per se presumably modulates H+
secretion in the distal nephron. In the absence of circulating
aldosterone renal acidification is impaired [10].
The secretory ability for H+ can be evaluated by measure-
ment of tubular reabsorption of HC03 (T0) over a
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normal range of arterial plasma bicarbonate concentrations
(22 to 26 mEqjliter) and under special circumstances over
lower and higher ranges. In healthy persons under physio-
logic conditions THco is complete at normal concentrations
of plasma bicarbonate. A urinary pH of 6.2 or less indicates
that urinary bicarbonate is negligible, and at normal plasma
bicarbonate concentrations virtually excludes a substantial
reduction in the H secretory rate of the kidney. The bicar-
bonate threshold is the lowest concentration of plasma bi-
carbonate at which bicarbonaturia occurs, normally 25 to
26 mEq/liter.
The adequacy of gradient-generating and acid-excreting
ability can be evaluated by measurement of the urinary pH,
titratable acid and NH during metabolic acidosis, either
spontaneous or induced. With only a small reduction in
plasma bicarbonate concentration, such as three to four
mEq/liter, normal subjects decreased urinary pH to values
less than 5.3 and increased excretion of titratable acid and
NH to values greater than 25 and 39 jsEq/min, respectively
[11, 12].
Renal acidosis
Renal acidosis is the clinical condition of metabolic
acidosis caused by impaired renal acidification. In this
consideration of renal acidosis, major attention will be
given to the physiologic character and pathogenetic mecha-
nisms of renal acidification defects that can cause acidosis
and certain of the immediate and remote effects of these
defects on other functions of the renal tubule. An acidosis-
causing impairment of renal acidification can result from
a large reduction in functioning renal mass, as reflected
by a large reduction in the glomerular filtration rate and the
clinical syndrome of "uremic acidosis." "Renal tubular
acidosis" (RTA) is a clinical syndrome of disordered renal
acidification characterized biochemically by minimal or no
azotemia, hyperchloremic acidosis, inappropriately high
urinary pH, bicarbonaturia, and reduced urinary excretion
of titratable acid and ammonium [8, 11—22]. The syndrome
reflects a disorder of renal acidification that can cause
acidosis with little or no apparent reduction in renal mass,
as measured by the glomerular filtration rate. In recent
years it has become apparent that several physiologically
distinct disorders of renal acidification can give rise to
RTA (Table 1).
Classic RTA (Table 2). In "classic" ("distal") RTA,
urinary pH is inappropriately high during severe as well as
mild degrees of acidosis, persisting urinary excretion of
bicarbonate is characteristic [19—21], and the complex
dysfunction of the proximal tubule characteristic of the
Fanconi syndrome (impaired tubular reabsorption of
glucose, phosphate and amino acids) is absent. In adult
patients with classic RTA, the amount of bicarbonate ex-
creted at both normal and reduced plasma bicarbonate con-
centrations is a trivial fraction of that filtered. This finding,
that the fractional excretion of filtered bicarbonate
(CHco/CJfl) is less than 5 % over an extended range of
normal and subnormal plasma bicarbonate concentrations,
permits the inference that reabsorption of bicarbonate in the
Table 1. Physiological characteristics of certain prototypic disorders of renal acidification
Renal tubular acidosis (RTA) Uremic
acidosis
Classic Type 2 RTA
("proximal")
Type 1,2 Hybrid
RTA
Mineralocorticoid
deficiency RTA
Type 1 RTA Type 1 RTA (?)a
("distal") with HCO
wasting
Urinary acidification
during acidosis impaired impaired intact impaired intact intact
Urinary pH >6.0 >6.9 <5.5 >6.0 <5.5 <5.5
Net acid excretion subnormal subnormal not reduced subnormal not reduced subnormal
Bicarbonaturiab <3% 5—10% <3%
during severe of filtered of filtered none of filtered none none
acidosis HCO load HCO load HCO load
Renal H secretion nearly moderately markedly markedly moderately nearly normal
(bicarbonate reab- normal reduced reduced reduced reduced to markedly
sorption) at normal reduced
plasma [HCOi
Bicarbonaturiab <3% 5—10% >15% >15% 5—10% <3% to>30%
at normal of filtered of filtered of filtered of filtered of filtered of filtered
plasma [HCO] HCO load HCO load HCO load HCO load HCO load HCO load
a The question mark indicates uncertainty as to whether classic RTA with bicarbonate wasting reflects a kind of renal acidification
defect identical to that designated as Type 1.
b The fractional excretion of filtered bicarbonate can be calculated: UHco X creat"HCO x Ucreat; the CO2 content of urine can be used
to approximate UHCOS.
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Table 2. Renal tubular acidosis —Type 1 (Classic RTA)
Primary — as part of no obvious systemic disease:
Sporadic — infantile and adult
Genetically transmitted
Genetically Transmitted Systemic Diseases — galactosemia (after
chronic galactose ingestion), hereditary fructose intolerance
with nephrocalcinosis (after chronic fructose ingestion), Ehlers-
Danlos syndrome, Fabry's disease, hereditary ellitocytosis
Metabolic Disorders — Hyperthyroidism with nephrocalcinosis,
Primary hyperparathyroidism with nephrocalcinosis
Hypergammaglobulinemic States — idiopathic hypergamma-
globulinemia, hyperglobulinemic purpura, cryoglobulinemia,
Sjogren's syndrome, lupoid hepatitis, lupus erythematosus
Medullary Sponge Kidney
Hepatic Cirrhosis
Drug-induced — arnphotericinB, Vitamin D-induced nephrocal-
cinosis
Pyelonephritis (?)
Renal Transplantation
proximal tubule (and the distal tubule) is not substantially
reduced, identifies the disorder as Type I RTA (Fig. 1),
and indicates that impaired renal acid excretion need not
be associated with renal "bicarbonate wasting" [16, 17,
19, 211. In patients with Type I RTA, acidosis results prin-
cipally from impaired acid excretion. Hence, correction of
acidosis is characteristically sustained by an amount of
alkali only a fraction more than the normal endogenous
production of noiwolatile acid: one mEq/kgJday in adults
[2, 16, 17, 19].
Classic RTA with bicarbonate wasting, in some children
with classic RTA, the disorder of renal acidification may be
physiologically indistinguishable from that described in
adults [19—21] and one to three mEq/kg/day of alkali may
be adequate replacement therapy [18, 20]. But several times
this amount of alkali has failed to correct the acidosis of
many infants with apparently classic RTA [12, 23—26],
suggesting the possibility that their renal acidification de-
fect may have been different from that described in adults
with classic RTA. Indeed, in two infants with classic RTA
recently studied by McSherry, Sebastian, and Morris [27],
"alkali-resistant" acidosis could be explained by an acidi-
fication defect quantitatively greater than that described in
adult patients (and children) with Type I RTA. In these two
infants CHCO1/CIfl was not trivial but substantial (6 to 9%),
as well as relatively fixed over a broad range of plasma
bicarbonate concentrations (15 to 26 mmoles/liter) (Fig. 2).
This value of CHco/CIfl, combined with a normal or near
normal glomerular filtration rate, translated to renal "bi-
carbonate wasting". At normal and reduced concentrations
of plasma bicarbonate, renal bicarbonate wasting can be
said to occur when net base excretion exceeds the rate at
which nonvolatile acid is produced endogenously. So
defined, bicarbonate wasting is quantitively more important
in the causation of acidosis than impaired acid excretion
per se (which predictably attends bicarbonate wasting
because of the inappropriately high urinary pH at which
bicarbonate wasting occurs). Impaired acid excretion per se
leads to acidosis only to the extent that the endogenously-
produced, nonvolatile acid titrates body buffers, including
plasma bicarbonate. Such a loss of base is relatively minor
and slowly developing compared to the loss of base which
can result from a substantial reduction in renal bicarbonate
reabsorption.1 Accordingly, in the two infants with classic
RTA and alkali-resistant acidosis, renal bicarbonate
wasting at normal plasma bicarbonate concentrations was
the major determinant of corrective alkali therapy (5 to
9 mEq/kg/day). Persistence of bicarbonate wasting at
substantially reduced plasma bicarbonate concentrations
accounted for the spontaneous occurrence of severe acidosis
1 This statement assumes no supernormal production of non-
volatile acid as could occur in diabetic ketoacidosis or lactic
acidosis.
ype 1
rmal
1 (?)
sting
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1 — 2 excretion of bicarbonate in renal tubular
acidosis: The physiologic spectrum of renal
tubular acidosis. The persistence of bi-
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marked bicarbonate wasting at normal
plasma bicarbonate concentrations (shaded
area).
aC
91
I
and its rapid recurrence after reduction in alkali therapy.
During severe acidosis the urinary pH was greater than
7, a finding reported frequently in infants with appa-
rently classic RTA and alkali-resistant acidosis but rarely
in adult patients with classic RTA [27]. In one of the two
infants with bicarbonate wasting, CHco/CIfl and the thera-
peutic alkali requirement decreased concomitantly and
progressively over four years, but renal bicarbonate wasting
continued. In these two children renal tubular acidosis has
persisted for four and five years, respectively, in contrast to
the spontaneously remitting "infantile" RTA previously
described.
Mechanism and pathogenesis of classic RTA. With the
exception of the magnitude of bicarbonaturia, the physio-
logical character of the renal tubular dysfunction in the two
children with classic RTA and renal bicarbol)ate wasting
was like that of Type 1 RTA: a) the pH of the urine re-
mained inappropriately high, and bicarbonaturia persisted
despite severe degrees of acidosis [20, 21]; b) when the
plasma bicarbonate concentration was progressively in-
creased from subnormal to normal levels, renal bicarbonate
reabsorption increased nearly commensurately with the
increase in filtered bicarbonate load [15, 16]; c) during
water diuresis, the rate of excretion of urinary bicarbonate
varied directly with urine flow [17]; d) during diuresis of
intravenously administered sodium phosphate (as a neutral
0.15 M solution), the pH of the urine changed little, but
the rate of excretion of titratable acid increased in direct
proportion to the rate of excretion of urinary phosphate
[16]; e) urinary excretion of potassium and fractional ex-
cretion of filtered potassium decreased when the plasma
bicarbonate concentration was increased from subnormal
to normal levels [8, 22]. In adult patients with RTA and
trivial bicarbonaturia, identical physiologic characteristics
have been explained as a consequence of an inability of the
distal segments of the nephron to generate or maintain
appropriately steep lumen-peritubular hydrogen ion gra-
dients [11, 16]. Such a defect could also account for a
substantial reduction of THCO5 in patients with otherwise
typical Type 1 RTA if, in these patients as in infants with
classic RTA and renal bicarbonate wasting, minimal
urinary pH was greater than 7.0 and urine flow was quite
high (Fig. 3). In patients with classic RTA, a greater than
usual fractional excretion of filtered bicarbonate could
then be only the physicochemical consequence of simul-
taneous and marked impairment in both the ability of the
renal tubule to generate steep lumen-peritubular H+ gra-
dients and to concentrate the urine (Fig. 3).
In patients with classic renal tubular acidosis, Seldin and
Wilson [17] considered the possibility that the inappro-
priately high urinary pH and attendant slight bicarbonaturia
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Fig. 2. Relationship between plasma concen-
tration, renal tubular reabsorption, and
urinary excretion of bicarbonate (Hco'
THCO7, and UHCO V, respectively) during
the 1st year of life in three infants with
apparently classic renal tubular acidosis,
two with bicarbonate wasting (RBW1,
RBW2) and one with classic Type 1 RTA
(cRTA). RBW1 (circles: • 51/ months;
C, 6 months; , 8 months; c, 11 months),
RBW2 (squares), cRTA (diamonds). Heavy
diagonal line: filtered load of HCO. Re-
printed with permission of the publisher
[271. Plasma HCO, mmoles/liter
V/C1=20%
[HCO],, 20 mmoles/Iiter
Up0 30mm Hg
.7 6.8 6.9 7.0 7.1 7.2 7.3
Minimal urine pH
Fig. 3. Theoretical relationship between fractional bicarbonate
excretion (CHC0S/CJfl) and urinary pH for three different urine
flows (V/C17) in hypothetical patients with classic Type 1 RTA and
differing minimal attainable urinary pH values. A constant value
of urinary carbon dioxide tension (30 mm Hg) and plasma bi-
carbonate concentration (20 mmoles/liter) was assumed in calcu-
lating CHCO/CIn. Patients with classic Type 1 RTA could have
unusually large fractional bicarbonate excretion (> 5%) if the
minimally attainable urinary pH were greater than 7.0 and
polyuria were present.
326 Morris et a!
might be the result of a small fixed leak of bicarbonate from
the proximal tubule; the amount of leaked bicarbonate
might be too small to result in massive bicarbonaturia but
too large to be completely titrated by secreted H in the
distal nephron, thereby causing only slight bicarbonaturia
and an inappropriately high urinary pH. These workers
attempted to distinguish between this possibility and the
generally inferred H gradient defect of the distal nephron
by examining the effect of water diuresis on urinary pH and
bicarbonate concentration in a patient with classic renal
tubular acidosis. Water diuresis was assumed not to change
the rate of delivery of bicarbonate out of the proximal
nephron. It was argued that if the urinary pH was inappro-
priately high because of excessive delivery of bicarbonate to
the distal nephron, suppression of water reabsorption in the
distal nephron would be expected to reduce the concentra-
tion of luminal bicarbonate and thereby reduce luminal pH
(assuming that carbon dioxide tension remained unchanged).
The bicarbonate concentration and pH of the urine would
therefore be expected to decrease as urine flow increased.
Alternatively, if the pH of the urine was inappropriately
high only because of a limitation on the steepness of the
lumen-to-peritubular fluid H+ concentration gradient in
the distal nephron, then suppression of water reabsorption
in the distal nephron would not necessarily be expected to
further reduce luminal pH or bicarbonate concentration.
Urinary pH and bicarbonate concentration would therefore
be expected to remain constant as urine flow increased.
In the patient studied with classic RTA, the observation
that urinary pH and bicarbonate concentration remained
constant as urine flow increased was interpreted as pro-
viding no evidence of bicarbonate leakage from the proxi-
mal nephron and consistent with an inability of the distal
nephron to establish steep pH gradients.
To reconsider the possibility that bicarbonate leakage
from the proximal nephron might occur in some patients
with classic RTA, we carried out similar studies during
water diuresis in six affected patients [281. Because chronic
metabolic acidosis is usually associated with extracellular
volume contraction and potassium depletion, both of which
can increase bicarbonate reabsorption, the studies were per-
formed during acidosis of short duration (induced by with-
holding alkali therapy or administration of ammonium
chloride) after sustained correction (months) of acidosis and
volume and potassium depletion. In two patients, the results
obtained were similar to those reported by Seldin and Wil-
son [17]. In the remaining four patients, however, including
two infants and two adult patients, a significant decrease in
urinary pH and bicarbonate concentration occurred as
urine flow increased (Fig. 4). But when the degree of aci-
dosis was considerably increased in one of the four patients
(Fig. 4), and when the duration of acidosis was prolonged
in another, both urinary pH and bicarbonate concentration
were less at low flows and the values of both remained
essentially constant as urine flow increased during water
diuresis. These findings are consistent with the occurrence
8
Plasma [HCO]
o 19.5
O 15.5
11.0
0_ 2j4
Urine flow, mi/mm
Fig. 4. Relationship between urinary pH, bicarbonate concentration
and flow during water diuresis in a child with Type I RTA during
mild (a), moderate () and severe () degrees of acidosis.
Urine flow ranged between 3 and 15% of GFR.
of a bicarbonate leak from the proximal nephron that could
be diminished either by marked reduction of filtered bi-
carbonate load or by some effect of chronic acidosis. These
findings therefore do not permit exclusion of the possibility
that in some patients with classic RTA, bicarbonate re-
absorption in the proximal nephron is impaired.
Yet, these findings provide neither compelling evidence
for a proximal leak of bicarbonate nor evidence against
the generally inferred gradient defect of the distal nephron.
Indeed, it may not be possible to distinguish between the
two possibilities by such studies during water diuresis.
When water diuresis is induced in any subject with a bi-
carbonate-rich urine the reduction of the pH of the urine is
the result of hydration of CO2 to H2C03, which ionizes to
HCO3 and H [29]. As water reabsorption diminishes,
generation of hydrogen ion in the lumen is favored by the
dilutional reduction in the concentration of luminal HCO
and by the absence of a dilutional reduction in the concen-
tration of dissolved luminal CO2. which is presumed to
remain in diffusion equilibrium with blood. Any dilution of
the initial H concentration (present only in nanomole
quantities) would be vastly offset by "new" H generated
from H2C03. Thus, hydrogen ion would be generated
within the lumen and the pH of luminal fluid would tend
7.4
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to fall during water diuresis, irrespective of the cause of an
initially high luminal concentration of bicarbonate. To the
extent that the distal nephron is unable to maintain a steep
lurnen-peritubular pH gradient because of abnormally high
permeability to hydrogen ion, back-diffusion of hydrogen
ion generated during water diuresis will mitigate any re-
duction of pH of the luminal fluid. But the effect of water
diuresis on the pH of the urine involves more than those
events which occur within the lumen of the distal nephron
[29]. Because the hydration of luminal CO2 to H2C03 is
uncatalyzed in the distal nephron [6], the reaction does not
proceed to completion there, but rather continues to occur
in the lower urinary tract (where back-diffusion of H is
less likely to occur). Accordingly, given a sufficiently high
initial luminal bicarbonate concentration in the distal
nephron, (and, as a consequence, a sufficiently high urinary
pH) a reduction of the pH of the urine during water diuresis
would not be surprising even if the presence of bicarbonate
in the urine was due solely to a limitation on the minimally
attainable pH in the distal nephron. Conversely, if the
initial luminal bicarbonate concentration is only modestly
increased, the pH of the urine might remain unchanged
during water diuresis even if the presence of bicarbonate in
the urine was due solely to a leak of bicarbonate out of the
proximal nephron; under these conditions the small amount
of H generated during water diuresis could be dissipated
by being both buffered by urinary nonbicarbonate buffers
(especially NH3/NHt) and lost through back-diffusion
across the normal distal nephron (perhaps as NH as well
as H).
That an abnormality of the permeability of the distal
nephron to H+ could underlie the impairment of urinary
acidification in patients with classic RTA is suggested by
the occurrence of apparently typical classic RTA in patients
with the nephropathy induced by amphotericin B [30], an
antifungal antibiotic that can alter cell membrane permeabil-
ity [311 and apparently increase passive H permeability in
certain Hf-secreting epithelia [32]. In studies of urinary
acidification in the turtle bladder, Steinmetz and Lawson
[32] demonstrated an amphotericin-induced acidification
defect with physiological characteristics remarkably similar
to those of classic RTA; net H+ secretion was normal or
only slightly reduced when passive electrochemical forces
restricting H+ secretion were minimized (cf. measurements
of THco at normal plasma [HCOfl), but H+ secretion
against a H+ concentration gradient was markedly reduced
(cf. measurements of net acid excretion during acidosis)
[32]. The impairment of acidification was inferred not to be
a failure of active H+ secretion but rather the result. of
increased passive permeability of the luminal membrane
and consequent increased H+ back-diffusion. The permeabil-
ity of the epithelium to potassium and to a lesser extent,
to sodium was also increased. Because the direction of the
electrochemical gradient for potassium in the distal nephron
is from cell to lumen, Steinmetz suggested that in ampho-
tericin nephropathy "a single alteration of the luminal
membrane could account for both the potassium wasting
and the failure to elaborate an acid urine".
Renal disease with the physiologic character of Type I
RTA can be genetically transmitted as an autosomal do-
minant trait [17, 33, 34]. The occurrence of RTA in those
heterozygous for the trait, and the occurrence of RTA in
patients with medullary sponge kidney and Ehlers-Danlos
syndrome [35], has led some workers to suggest that the
acidification defect reflected a "structural" rather than a
"metabolic" defect [35]. The acidification defect might,
of course, result from a metabolic abnormality of some
epithelial membrane. The functional integrity of certain
membranes involved in the renal acidification process might
require a complete complement of certain proteins which
might have, or influence, enzymatic activity. The asso-
ciation of familial RTA and elliptocytosis [36] suggests the
possibility that the renal tubule and red blood cell membrane
share a common protein. Abnormalities in red blood cell
electrolyte flux have been claimed in patients with Bartter's
syndrome [37], which in some patients might stem from a
genetic abnormality of the renal tubule [38].
When neither toxic nor genetic in cause, Type I RTA in
adults occurs predominantly in women, usually in associa-
tion with disorders characterized by hypergammaglobu-
linemia [12, 39—45], most commonly Sjogren's syndrome
[40—43]. The association of RTA and hypergammaglobu-
linemia appears to be more than coincidental, but RTA
seems not to be caused by hypergammaglobulinemia per se
[40, 42—44]. Rather, several lines of evidence support the
suggestion that RTA can be the functional renal expression
of a more general autoimmune disorder (e. g., Sjogren's
syndrome) [40—45] that can give rise to hypergammaglobu-
linemia. In the families of three patients with RTA and
hypergammaglobulinemia, Wilson, Williams, and Tobian
[45] found a high frequency of immunological abnorma-
lities. In twelve patients selected for Sjogren's syndrome,
Talal, Zisman, and Schur [40] found RTA in six, who as a
group had higher serum gamma globulin concentrations and
more autoantibodies than those with normal renal acidi-
fication. In two of the patients with RTA, these workers
described IgG in the cytoplasm of the renal tublules
(immunofluorescence) and, in another patient with
RTA, IgG was found in cellular infiltrates around the renal
tubules. In each of four patients with classic RTA, including
three with hypergammaglobulinemia (idiopathic, Sjögren's
syndrome, hemolytic anemia with oligophrenia) and one
without hypergammaglobulinemia, Pastemack and Linder
[44] described immunoglobulin-containing mononuclear
cellular infiltrates around the distal renal tubules and bound
immunoglobulin and complement in tubules. The sera of
the patients contained antibodies reacting with a variety
of tissue antigens, among them renal tubular antigens.
That RTA might result from an autoimmune disorder
initiated by specific renal tubular antigens is suggested by
recent work of Kiassen et al [46]. These workers demon-
strated that in rats immunized with an homologous kidney
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suspension in Freund's complete adjuvant (combined with
administration of Bordetella pertussis), four patterns of
immunoglobulin accumulation occurred in the renal tubule
(detected with immunofluorescence): 1) granular deposits
of IgG and fl1C along the basement membrane of proximal
tubules, 2) accumulation of lgG and often 131C as well in the
brush border of proximal tubules, 3) and 4) accumulation
of IgG in basilar portions of tubules in the ascending thick
limb or loops of Henle and in distal convoluted tubules.
Animals with the last three patterns had circulating auto-
antibodies which were capable of reacting in vitro with the
corresponding segment of the nephron. The globulin de-
position presumably represented antibody combined with
kidney-specific antigen present in the basal membrane.
On the basis of studies of NZB mice, which develop an
autoimmune disorder characterized by lymphocytic inf II-
tration of the salivary glands and the kidneys, and the
finding in patients with Sjogren's syndrome of a renal ab-
normality (intracytoplasmic tubular inclusion) that is
presumably virus-induced, Talal [43) suggested that the
pathogenesis of Sjogren's syndrome and RTA may involve
an interplay of genetic predisposition, virus-induced "subtle
antigenic alteration" of the salivary duct and an abnormal
immune response. The renal abnormality expressed as RTA
might be initiated by a similar antigenic alteration of the
renal tubule or by sensitized lymphocytes not induced by,
but attracted to, the kidney by cross-reacting renal antigens.
Of course, the concurrence of classic RTA and an auto-
immune disease of the kidney, even one initiated by a
kidney-specific renal antigen, does not necessarily mean
that the autoimmune disease necessarily causes or even
contributes to the renal dysfunction. A renal abnormality
that could cause RTA without immunologic mediation
might also be capable of initiating an autoimmune disorder
of the kidney.
"Incomplete" RTA. In patients with so-called "in-
complete" RTA, systemic acidosis is not present and net
acid excretion does not appear to be frankly subnormal,
although the pH of the urine is clearly inappropriately high
when measured during NH4C1-induced acidosis [11]. In
these patients, urinary ammonium characteristically con-
stitutes a greater than normal fraction of urinary acid, both
before and during induced acidosis; in some patients,
ammonium excretion increases to frankly supernormal
rates during NH4CI-induced acidosis. In several patients
with incomplete RTA, "classic" RTA has occurred in
association with a generalized diminution in renal function
as reflected by a reduction in glomerular filtration rate (al-
though not such as to cause azotemia) [47].
Type 2 (Proximal) RTA (Table 3). In patients with
Type 2 RTA ("proximal" RTA), under normal physiologic
conditions, the identifying observation that at
normal plasma bicarbonate concentrations is reduced by
at least 15%, implicates the acidification process of the
proximal tubule [19, 21, 22]. In prototypic Type 2 RTA, the
urine pH is inappropriately high and bicarbonaturia occurs
methyl-5-chrome(diacramone),
Table 3. Renal tubular acidosis — Type 2 ("Proximal")
Associated Multiple Dysfunctions of Proximal Tubule:
Primary (as part of no obvious systemic disease):
Sporadic
Genetically transmitted
Genetically transmitted systemic disease:
Cystinosis, Wilson's disease, Lowe's syndrome, tyrosinosis,
hereditary fructose intolerance (experimentally induced and
short-term fructose ingestion)
Metabolic disorders:
Vitamin D deficiency; secondary hyperparathyroidism
Metabolic disorders of uncertain genetic status:
Hypercalciuric rickets of Friedmann and Dent (children)
Pseudo-vitamin D deficiency rickets (children)
Disorders ofprotein metabolism:
Nephrotic syndrome, multiple myeloma, idiopathic immuno-
globulinuria (Harrison-B!ainey syndrome?, Sjögren's syn-
drome, amyloidosis
Medullary cystic disease
Renal transplantation
Drugs:
Outdated tetracycline,
6-mercaptopurine
Heavy metals:
Lead?, cadmium
Experimentally induced (animals):
Malcie acid, malonic acid
Unassociated with Multiple Dysfunctions of Proximal Tubule:
Primary:
Infantile
Transient — (Soriano-Edelmann syndrome)
Persisting
Adult: (York-Yendt syndrome) (vitamin D deficiency?)
Drug induced:
Sulfanilamide
only during moderate or mild degrees of acidosis; during
more severe degrees of acidosis, bicarbonaturia disappears,
urinary pH decreases to normal minima, and acid excretion
is not reduced, suggesting that the acidification process of
the distal most nephron is intact [18—22] (Tables I and 3;
Figs. I and 5). The physiologic characteristics of Type 2
RTA are those predicted by the formulation of Worthen
and Good [48] and were first demonstrated by Lamy et al
in a child with Fanconi's syndrome as part of Lowe's syn-
drome [49]. Type 2 RTA almost always occurs as part of
a more complex dysfunction of the proximal tubule and is
apparently always that type of RTA associated with the
Fanconi syndrome [18, 19, 221.
In some patients with a greater than 15% reduction in
THCO at normal plasma bicarbonate concentrations, the
acidification process of the distal nephron also appears to
be impaired; over a broad range of reduced plasma bicar-
bonate concentrations, T0- is just less than complete and
urinary pH remains inappropriately high. Such findings
would appear to reflect a hybrid of Types I and 2 RTA [21].
As in patients with classic bicarbonate-wasting RTA [27],
the amount of alkali required to sustain the correction of
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Fig. 5. Schematic representation of the Proximal Renal Acidification Defect
proximal renal acidification defect in Type 2 Normal I
RTA. Effect of changes in plasma b/carbon- 26 mmoles/liter 15 mmoles/liter 18 mmoles/liter 26 mmoles/liter
ate concentration on bicarbonate delivery I1co.to the distal nephron and, as ci consequence,
on urinary pH and bicarbonate excretion.
A) in normal subjects, at normal plasma
bicarbonate concentrations, approximately
15% of the filtered HCO load escapes
reabsorption proximally and is reabsorbed
in the distal nephron; urinary bicarbonate
excretion is nil, urinary pH is appropriately
low, and net acid excretion is normal; B) 85/0
in patients with Type 2 RTA, at reduced
plasma bicarbonate concentrations, bi-
carbonate excretion may also be nil, urinary
pH may be appropriately low, and net acid
excretion may not be reduced despite a
reduction in the rate at which bicarbonate
150
can be reabsorbed in the proximal tubule. /0
This is because the amount of HCO escap-
ing reabsorption proximally and delivered
to the distal nephron may not be super- pH 5.5 pH 5.5 pH 6.5
normal when the amount of bicarbonate A B C D
presented to the proximal tubule for reab-
sorption is also markedly reduced; C) when, however, the plasma bicarbonate concentration is modestly increased (by administration
of NaHCO3), supernormal amounts of bicarbonate are delivered distally because the modest increase in filtered load of bicarbonate
cannot be reabsorbed by the defective proximal tubule. As a consequence, some bicarbonate escapes reabsorption in the distal
nephron, urinary pH becomes inappropriately high, and net acid excretion becomes reduced; D) if the plasma bicarbonate con-
centration and filtered bicarbonate load are increased to normal levels, the amount of bicarbonate escaping reabsorption proxi-
mally greatly exceeds the reabsorptive capacity of the normal distal nephron and massive bicarbonaturia occurs. In the illustration
of Type 2 RTA, renal tubular reabsorption of bicarbonate (Tno) at normal plasma bicarbonate concentration (26 mmoles/liter)
is reduced by 25%.
acidosis in patients with Type 2 RTA is determined prin-
cipally by the magnitude of bicarbonate wasting at normal
plasma bicarbonate concentrations [20, 21].
Experimental Type 2 R TA (hereditary fructose intolerance).
A physiologic prototype of Type 2 RTA (and the complex
proximal dysfunction of Fanconi's syndrome) can be in-
duced in patients with hereditary fructose intolerance by
the experimental administration (or continued ingestion)
of fructose [19, 50]. Renal function appears to be normal
when those affected abstain from ingesting fructose [19,
51]. The experimental disorder therefore provides a model
of Type 2 RTA that is uncomplicated by whatever secon-
dary phenomena attend chronicity of the clinical disorder.
The model thus affords an opportunity to investigate not
only the metabolic pathogenesis of Type 2 RTA but also
the non-genetic determinants of the expression of a genetic
renal disease.
In hereditary fructose intolerance the metabolic abnor-
mality induced by fructose is initiated by cellLilar accumu-
lation of fructose-I-phosphate (F-l-P) in tissues deficient
in aldolase activity toward F-l-P: kidney [52], liver [53]
and small bowel [54]. These organs normally extract
fructose briskly and convert it to glucose, pyruvate and
lactate, predominantly via F-I-P and the triose products of
its aldolase cleavage. Fructokinase catalyzes the phosphory-
lation of fructose to F-l-P and is intact in these patients.
Aldolase "B" has strong cleaving activity toward F-I-P
and strong condensing activity toward dihydroxyacetone
phosphate and D-glyceraldehyde-phosphate [55], in keeping
with the gluconeogenic capacity of liver and kidney. Trio-
kinase catalyzes the phosphorylation of D-glyceraldehyde,
one of two aldolase cleavage products of F-I-P. Since fructo-
kinase and aldolase B appear to occur only in the liver,
kidney and small bowel [56], only these organs can accumu-
late F-I-P because of deficient aldolase activity.
The finding that fructokinase, aldolase B and triokinase
occur only in the cortex of normal mammalian kidney and
not in the medulla [57] constitutes strong evidence that only
the cortex normally metabolizes fructose via F-I-P and its
aldolase cleavage. Deficient renal aldolase would therefore
impair only renal cortical metabolism of fructose. Ac-
cordingly, the experimental renal tubular dysfunction is not
associated with an impairment in renal concentration
function, as judged by the rate of solute-free water reab-
sorption during antidiuresis and mannitol diuresis [58].
Osmolar clearance increases during the experimental dys-
function, but the rate of free-water reabsorption is identical
to that obtained at comparably increased values of osmolar
clearance attained during antidiuresis with mannitol alone.
These physiologic and enzymatic data constitute strong
evidence that the concentrating mechanisms of the renal
medulla are not involved in the experimental defect.
The experimental defect, however, appears to affect the
cortical diluting segment. In studies on two patients with
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hereditary fructose intolerance we examined the effect of
administered fructose on solute-free water clearance and
urine flow during water loading, alone and in combination
with an intravenous infusion of hypotonic saline. Under
these conditions of reduced secretion of antidiuretic hor-
mone, the distal portions of the nephron are relatively
impermeable to water. Urine flow can then be regarded as
an approximate measure of the rate at which fluid is de-
livered out of the proximal convoluted tubule, and free
water clearance can be used to estimate the rate at which
solute is reabsorbed in the diluting segment. With the
occurrence of the experimental defect, urine flow increased
abruptly, but at any urine flow, free water clearance was
less during the experimental defect than during control
studies in which urine flow was increased by infusion of
hypotonic saline or mannitol alone [58]. Evidence of im-
paired renal diluting ability would appear to implicate the
cortical diluting segment since the function of the medullary
ascending limb appears to be intact. These findings suggest
the possibility that the fructose-induced metabolic abnor-
mality of the renal cortex affects the distal as well as the
proximal nephron. However, a reduced rate of solute
reabsorption in the cortical diluting segment could be the
consequence of delivery to that segment of an increased
amount of HCO [59), a relatively impermeant anion. In
order to distinguish between these two possibilities we
induced the experimental dysfunction during experimen-
tally-induced acidosis and water diuresis. Predictably,
urinary pH changed little and bicarbonaturia did not occur
[19]. Under these conditions, when urine flow increased,
free water clearance increased appropriately (Morris,
R. C., Jr.: unpublished observations). It would appear
then that the functional integrity of the cortical diluting
segment can remain intact during the experimental dys-
function. Conceivably, the metabolic abnormality under-
lying the experimental dysfunction may be restricted to the
proximal tubule.
A possible clue to the pathogenesis of the experimental
renal dysfunction may be provided by the recent observation
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that the dysfunction is strikingly modulated by circulating
parathyroid hormone [60]. In a woman with hereditary
fructose intolerance and hypoparathyroidism the experi-
mental dysfunction was strikingly attenuated or non-
demonstrable unless or untilf ructose and parathyroid hor-
mone were administered in sustained combination. There-
upon, a renal dysfunction of characteristic type and severity
occurred almost immediately (Fig. 6). This effect of para-
thyroid hormone appeared to involve more than physiologic
summation. In patients with hereditary fructose intolerance
the fructose-induced abnormality of renal metabolism that
depends on the accumulation of F-i-P [53] probably
involves a severe reduction in intracellular inorganic
phosphate and ATP [61—63]. In vitro studies provide no
evidence that parathyroid hormone increases the renal
extraction of fructose or the activity of fructokinase (Mor-
ris, R. C., Jr.: unpublished observations). Preliminary
results suggest that the experimental dysfunction may be
partially reversed by the experimental administration of
sodium phosphate (Morris, R. C., Jr.: unpublished obser-
vations).
Pathogenetic role of hyperparathyroidism in Type 2 renal
tubular acidosis. An impairment of renal acidification phy-
siologically similar to that occurring in patients with Type 2
RTA can be induced experimentally in normal subjects by
the acute administration of parathyroid hormone: at nor-
mal plasma bicarbonate concentrations and during mild
degrees of acidosis, the urinary pH increases and brisk
bicarbonaturia occurs; during more severe degrees of aci-
dosis, the urine remains bicarbonate-free and appropriately
acidic [64]. This observation, together with the observation
that many patients with Type 2 RTA are chronically hypo-
calcemic [65], raises the possibility that the impairment of
renal bicarbonate reabsorption in Type 2 RTA is in part
due to increased circulating levels of parathyroid hormone.
This possibility is supported by the observation that serum
concentrations of parathyroid hormone are increased in
hypocalcemic patients with Type 2 RTA [66J, and that
maneuvers designed to suppress parathyroid hormone Sc-
Fig. 6. Effect of intravenously administered
fructose on the fractional excretion offiltered
bicarbonate (clearance of bicarbonate ex-
pressed as percentage of clearance of inulin;
lower portion of figure) in a patient with
hereditary fructose intolerance (HFI) and
intact parathyroid function (E) and in a
patient with hereditary fructose intolerance
and hypoparathyroidism, before (0) and
during (.) intravenous administration of
parathyroid extract (PTE). Reprinted with
permission of the publisher [60].
100 150
Time, minutes
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cretion are attended by a striking amelioration of the defect
in renal bicarbonate reabsorption [66—68].
In each of six hypocalcemic patients with Type 2 RTA
studied in our laboratory, THco at normal plasma bicar-
bonate concentrations increased significantly and the
fraction of the filtered load of bicarbonate excreted
(CHco/CJfl) decreased significantly when the serum con-
centration of calcium was increased to normal and super-
normal levels by continuous intravenous administration of
calcium gluconate; the results of the studies performed on
four patients are depicted in Fig. 7. In each of three studies
in which serial determinations of the concentration of serum
parathyroid hormone (PTH) were made before and during
calcium administration, increased baseline concentrations
decreased to or toward normal values as the concentration
of serum calcium and THc0- increased. The improvement in
renal bicarbonate reabsorption was reversed almost im-
mediately when parathyroid extract was adminstered intra-
venously, even though the administration of calcium was
continued and the concentration of serum calcium further
increased to frankly supernormal levels. Accordingly, the
calcium-induced enhancement of renal bicarbonate reab-
sorption did not require induction of frank hypercalcemia
and the parathyroid hormone-induced suppression of renal
bicarbonate reabsorption did not require the presence of
hypocalcemia. Furthermore, changes in renal bicarbonate
reabsorption apparently can be effected by non-acute
changes in the concentration of serum calcium and para-
thyroid hormone; in one patient with Type 2 RTA in whom
THco at normal plasma bicarbonate concentrations was
measured before and during administration of vitamin D,
improvement in renal bicarbonate reabsorption attended
a gradual change in the concentration of serum calcium
(and presumably, in the concentration of serum PTH)
(Fig. 8).
These results indicate that hypocalcemia in some way
contributes to the pathogenesis of Type 2 RTA and suggest
the possibility that increased circulating levels of para-
thyroid hormone can be a determinant of the renal acidi-
fication defect in this disorder. In the acute studies, the
immediacy with which renal bicarbonate reabsorption first
increased and then decreased when the circulating level of
parathyroid-hormone (PTH) was experimentally altered
are in accord with the immediacy with which adenyl cyclase
activity in the mammaliam renal cortex responds to changes
in circulating parathyroid hormone [69,70], and the imme-
diacy of the characteristic renal functional response to
administered parathyroid hormone [64, 71]. Recently
reported studies of Agus et al [72] indicate that at least
part of the characteristic functional response of the kidney
to parathyroid hormone (suppression of renal reabsorption
of sodium and phosphate) is mediated in the proximal con-
voluted tubule, and they therefore provide further support
for the proposition that increased circulating levels of PTH
might cause or contribute to a renal acidification defect of
the proximal nephron.
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Fig. 7. The relationship between the fraction of the filtered load
of bicarbonate excreted (CHcos/CIfl) at normal plasma bicarbon-
ate concentrations and serum calcium concentration during acute
intravenous administration of calcium gluconate in four patients
with Type 2 RTA: U, Sjögrens syndrome 0, idiopathic; • and 0,
ma/absorption syndrome. Note that in one patient bicarbonaturia
disappeared (urine pH <5.5) when the serum calcium concen-
tration was increased to normal levels.
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Fig. 8. Relationship between urinary bicarbonate excretion and
plasma bicarbonate concentration during intravenous administra-
tion of NaHCO3 in a patient with Type 2 RTA and the Fanconi
syndrome associated with intestinal ma/absorption, before (.)
and during (o) administration of vitamin D therapy. Dashed line
refers to normal subjects. The shaded area represents the normal
range of arterial plasma bicarbonate concentration.
But to attribute the PTH-related changes in renal bicar-
bonate reabsorption only to a direct effect of parathyroid
hormone on tubular epithelium may be premature. Since
injection of calcium into one renal artery can cause ipsi-
lateral reduction of renal blood flow [73], and since in-
jection of even minute amounts of highly purified parathy-
roid hormone into the renal artery can cause an increase in
renal blood flow [74], the possibility must be considered
that the PTH-related changes in bicarbonate reabsorption
in patients with Type 2 RTA are mediated in part by changes
in renal hemodynamics. Hemodynamic changes could
8
6Q • Before vitamin D therapy
serum Ca + =7.5 mg/lOU ml
IOO-CHCQI/CLfl=IS%
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be mediated by the release of cyclic adenosine mono-
phosphate or other vasoactive substances into the renal
circulation [75]. Some workers would appear to discount
the possible role of renal hemodynamics in mediating
changes in renal bicarbonate reabsorption because of the
absence of large calcium- or PTH-induced changes in
creatinine excretion or clearance [68, 76]. But when clear-
ances of inulin and para-aminohippurate (C1, Cpah) are
measured, evidence of hemodynamic changes is usually
obtained, even with amounts of administered calcium or
highly-purified parathyroid hormone that are just effective
in changing renal reabsorption of bicarbonate (Sebastian,
A., McSherry, E., and Morris, R. C., Jr.: Unpublished ob-
servations). In fact, the calcium-induced increase in renal
bicarbonate reabsorption, and its reversal with PTH, corre-
lates significantly with the apparent filtration fraction
(CIn/CPah) (Fig. 9). The observation that fractional bicar-
bonate excretion decreases when filtration fraction in-
creases (during calcium infusion) and increases when fil-
tration fraction decreases (during PTH infusion) accords
with current views of the effect of changes in filtration
fraction on renal sodium reabsorption [77].
Renal tubular acidosis associated with mineralocorricoid
deficiency. Hyperchloremic acidosis occurs commonly in
patients with congenital or acquired disorders in which
adrenal cortical production of aldosterone is subnormal:
Addison's disease, salt-losing congenital adrenal hyperplasia
[78—80] and isolated hypoaldosteronism [81—86]. In some
of those affected it has been demonstrated that acidosis can
occur in the absence of apparent renal disease [811 and that
acidosis can be corrected with mineralocorticoid replace-
ment therapy [82, 83]. Systematic studies of the pathogenesis
of acidosis in patients with these disorders have not been
reported. In an infant with hyperchloremic acidosis asso-
ciated with salt-losing congenital adrenal hyperplasia,
Oetliker and Zurbrugg [78] provided evidence of impaired
renal acidification; during severe degrees of acidosis the
pH of urine was appropriately low but substantial bicar-
bonaturia occurred at a lesser degree of acidosis, i. e., the
bicarbonate threshold was reduced. On the basis of these
findings, which are similar to those observed in patients
with prototypic "proximal" RTA, it was inferred that
reabsorption of bicarbonate in the proximal tubule was
impaired. On the basis of the reported magnitude of bi-
carbonaturia, however, which amounted to only approxi-
mately seven percent of the filtered bicarbonate load, the
proximal tubule cannot be conclusively implicated. Mea-
surements of THCO2 at normal plasma bicarbonate con-
centrations have not been reported in patients with mi-
neralocorticoid deficiency.
In a woman with persisting hypoaldosteronism asso-
ciated with hypo-reninemia, diabetes mellitus, and pre-
sumed pyelonephritis, we have identified a renal acidi-
fication defect similar to that occurring in patients with
prototypic "proximal" RTA; the reduction in THCO5 at
normal plasma bicarbonate concentrations was, however,
Fig. 9. Relationship between the fraction of the filtered load of
bicarbonate excreted (CHC0S/CJfl) at normal plasma bicarbonate
concentrations and the apparent filtration fraction during acute
intravenous infusion calcium gluconate (four studies, lower figure)
and at varying intervals before and during administration of
vitamin D therapy (upper figure) in a patient with Type 2 RTA
associated with intestinal ma/absorption. For the upper figure
each point represents the mean value of three or more successive
values during sustained correction of acidosis with oral alkali
therapy.
insufficient to implicate the acidification process of the
proximal nephron. The patient did not have Fanconi's
syndrome. Before alkali therapy was initiated, the patient
continually excreted highly acidic urine (pH 4.8 to 5.3) and
appeared to be in H+ balance; urinary net acid excretion
(1.2 mEq/kg body wt/day) was not reduced and was
approximately equal to the estimated endogenous produc-
tion rate of non-volatile acid (1.0 mEq/kg body wt/day).
Sustained correction of acidosis required the administration
of slightly more than two mEq of NaHCO3/kg body wt
per day. At normal plasma bicarbonate concentrations,
renal bicarbonate reabsorption was reduced by six to eight
percent. The observed reduction of T0- may have some-
what underestimated the actual reduction in H+ secretory
rate since the measurement was made at a time when the
patient may have been slightly sodium-depleted. These
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findings, which indicate a modest reduction of renal H
secretory rate but apparent intactness of the H+gradient
generating ability of the distalmost segments of the nephron,
are consistent with an acidification defect localized to the
distal nephron (e. g., distal convoluted tubule), the major
apparent site of action of aldosterone. Because of the
possibility that aldosterone normally stimulates Na
transport in the proximal as well as distal nephron [87, 88],
the possibility exists that aldosterone deficiency can lead to
a reduction of H+Na+ exchange at that site.
In adrenalectomized dogs, Kurtzman, White, and
Rogers [10] reported that the urine contained a small
amount of bicarbonate during spontaneously occurring
acidosis. When the plasma bicarbonate concentration was
progressively increased to normal levels the rate of ex-
cretion of urinary bicarbonate increased little; at normal
plasma bicarbonate concentrations, fractional bicarbonate
excretion (FBE) was at most two percent. This finding is
difficult to interpret however, since the authors reported no
data relating to the state of sodium balance in the dogs. If
the dogs were sodium-depleted at the time of the study, a
greater fractional bicarbonate excretion at normal plasma
bicarbonate concentrations might possibly have been pre-
vented by whatever compensatory physiological factors
operate to re-establish sodium balance during mineralo-
corticoid deficiency. Other workers have found that adre-
nalectomized dogs can excrete appropriately acidic urine
during severe acidosis [89].
Sodium and potassium excretion in renal tubular acidosis.
Renal potassium wasting, renal sodium wasting, and se-
condary hyperaldosteronism are common complications of
both Types 1 and 2 RTA [90] (Fig. 10). In patients with
classic RTA, but not in patients with Type 2 RTA, correc-
tion of acidosis with alkali therapy is predictably attended
by a reduction in the urinary excretion rate of sodium, po-
tassium (Fig. 11) and aldosterone; with sustained correction
of acidosis, the external balances of potassium and sodium
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Fig. 10. Relationship between urinary potassium excretion and
serum potassium concentration in patients wit/i renal tubular
acidosis in whom Correction of acidosis was sustained (closed
symbols) and in normal subjects experimentally depleted of
potassium by dietary restriction (open circles, crosses, x 's) (*, *
Some of the subjects represented by were mildly alkalotic and
were excreting significant amounts of urinary bicarbonate (*);
the subjects represented by+were moderately alkalotic and
were excreting more than 50 mEq of bicarbonate daily (**);
the subjects represented by x were given large amounts of
desoxycorticosterone after hypokalemia supervened (*). Re-
printed with permission of the publisher [91]. (*) Huth, E. J..
Squires, R. D., Elkinton, J. R.: J. Clin. Invest. 38: 1149, 1959.
(**) Black, D. A. K., Milne, M. D.: Clin. Sci. II: 397, 1952.
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Plasma HCO, mmoles/liter
Fig. 11. Effect of experimentally increasing plasma bicarbonate
concentration (intravenous administration of sodium bicarbonate)
onfractionalpotassiuni excretion (CK/CJfl) and urinary bicarbonate
excretion (11HCOS V/C,,,) in a patient wit/i Type 2 RTA and tile
Fanconi syndrome ( A) and in a patient with classic, Type I
RTA (.).
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may become sufficiently positive to correct hypokalemia
and sodium depletion [90]. in most patients with Type 1
RTA, potassium supplements are not required to maintain
normokalemia when correction of acidosis is sustained.
These observations provide the basis for the inference
that renal wasting of potassium and sodium in classic RTA
is a consequence of the renal acidification defect and not
the consequence of independent abnormalities in renal con-
servation of sodium and potassium. According to the con-
ventional formulation of the pathogenetic mechanisms, the
gradient restriction of renal H+ secretion reduces the rate of
renal H+Na+ exchange, which results in a "reciprocal"
increase in renal K+Na+ exchange and urinary sodium
loss; sodium depletion leads to secondary hyperaldoster-
onism. With correction of acidosis, the attendant increase
in intraluminal pH (reflected by the increased urinary pH)
is presumed to remove the inferred gradient restriction on
renal H+ secretion. As a consequence, the rate of H+Na+
exchange increases, the rate of K+Na+ exchange de-
creases "reciprocally" and the urinary excretion rates of
sodium and potassium decrease; correction of sodium-
depletion would tend to remove the stimulus to hyper-
aldosteronism [901.
But the observation in patients with classic RTA that
urinary sodium and potassium excretion decrease when
acidosis is corrected [90, 91] does not necessarily indicate
that renal wasting of these cations is entirely due to some
consequence of the inferred H+ gradient-defect. In five of
nine patients with classic RTA studied during sustained
correction of acidosis with potassium bicarbonate, a
persisting impairment in renal conservation of sodium was
observed when dietary intake of sodium was restricted [92]
despite values of urinary pH near or greater than those of
arterial blood, i. e., no apparent gradient-restriction on H+
secretion. Moreover, in some patients with classic RTA,
frank renal potassium wasting persists, in association with
persisting hyperaldosteronism, despite sustained correction
of acidosis with alkali therapy and the provision of a normal
or even supernormal amount of dietary sodium [91]. To
what extent such impairment in the renal conservation of
sodium and potassium might result from primary abnorma-
lities of renal sodium and potassium transport, or from
secondary functional or structural abnormalities of the
kidney (e. g., juxtaglomerular cell hyperplasia, nephrocal-
cinosis), remains to be elucidated.
In contrast to patients with classic RTA, in patients with
Type 2 RTA, renal potassium wasting either occurs or
becomes more severe when acidosis is corrected with alkali
therapy and predictably persists when correction of acidosis
is sustained [9l1(Fig. II). These findings can be attributed
in part to excessive sodium bicarbonate delivery to the
distal nephron. Because of the impairment of proximal
reabsorption of bicarbonate in these patients, raising the
plasma bicarbonate concentration from subnormal to
normal levels has the immediate and sustained effect of
swamping the distal nephron with sodium and bicarbonate.
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Fig. 12. Relationship between fractional potassium excretion
(CK/Cffl) and urinary bicarbonate excretion (UHcoV/CIfl) in
patients with Type 2 renal tubulara cidosis associated with the
Fanconi syndrome (closed and three-quarter closed symbols) and
in patients with classic renal tubular acidosis (open and three-
quarter open symbols) in whom the plasma bicarbonate concen-
tration was maintained at normal levels (22 to 26 mmoles/liter)
for more than two months (closed and open symbols) or was
rapidly increased to normal levels (intravenous administration of
sodium bicarbonate) (three-quarter open symbols). Identical
geometric symbols represent measurements in a single patient.
Reprinted with permission of the publisher [221.
In the presence of a continued stimulus for sodium reab-
sorption (e. g., hyperaldosteronism), the delivery to the distal
nephron of such supernormal amounts of sodium and the
relatively impermeant bicarbonate anion would be expected
to increase intraluminal negativity, augment net potassium
secretion in the distal nephron, and thereby promote renal
potassium wasting. In at least some patients with Type 2
RTA, as in some patients with Type I RTA, hyperal-
dosteronism persists despite sustained correction of acidosis
and the provision of normal or supernormal amounts of
dietary sodium. During sustained correction of acidosis the
fraction of the filtered load of potassium excreted frequently
exceeds 1.0, which indicates net renal secretion of potassium,
and varies directly with the magnitude of reduction of
renal bicarbonate reabsorption [91] (Fig. 12).
Uremic acidosis
Irrespective of cause, chronic progressive renal disease
usually results in some degree of systemic acidosis when the
glomerular filtration rate is reduced to 25 mI/mm or less
[93—95]. The occurrence of acidosis under these circum-
stances has been attributed to two interrelated disturbances
of the renal acidification process: impaired reabsorption of
bicarbonate [96] and impaired production of ammonia
[97]. Both disturbances have been commonly regarded as
consequences largely of a reduction in number of nephrons
rather than of damage to the surviving nephrons [98—101].
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impaired Renal Bicarbonate Reabsorption. In many pa
tients with chronic azotemic renal failure, renal reabsorp-
tion of bicarbonate is reduced at normal and at slightly
subnormal plasma bicarbonate concentrations [76, 95, 96,
100, 102—105]. This abnormality was first recognized by
Schwartz et al [96]; substantial bicarbonaturia occurred
(20 to 85 mmoles/day) in five of twelve patients with chronic
renal failure who were studied after their acidosis had been
corrected with alkali therapy [96]. A substantial reduction
in bicarbonate reabsorption per nephron is apparently not
uncommon in patients with chronic renal failure [100, 105].
In three of five patients with chronic renal failure and gb-
merular filtration rates of less than 20 mI/mm, fractional
excretion of filtered bicarbonate ranged from 5 to 20% at
normal plasma bicarbonate concentrations [100].
In some studied patients with chronic renal disease,
despite considerable reduction of glomerular filtration rate,
the amount of excreted bicarbonate at normal plasma bi-
carbonate concentrations was sufficiently large that urinary
net base excretion exceeded the estimated or simultaneously
measured endogenous production rate of non-volatile acid
[96, 103, 105]. In these patients, therefore, as in patients with
Type 2 RTA, frank renal bicarbonate wasting occurred and
the amount of bicarbonate excreted in the urine at normal
plasma bicarbonate concentrations would have been a
quantitatively more important determinant of therapeutic
alkali requirements than the associated reduction of urinary
acid excretion. Maintenance of normal plasma bicarbonate
concentrations in some patients has necessitated admi-
nistration of as much as 180 mmoles of bicarbonate daily,
perhaps two or three times the amount needed to titrate
endogenously produced non-volatile acid [106]. In these
patients, as in patients with Type 2 RTA, acidosis recurs
promptly when corrective alkali therapy is withheld, and
the degree of acidosis that occurs is largely attributable to
the cumulative urinary loss of bicarbonate [96, 102, 105].
Schwartz et al [96] and Relman [107] suggested the
possibility that impairment of renal bicarbonate reabsorp-
tion is characteristic of advanced renal failure, possibly
even in those patients who do not have substantial bicarbo-
naturia at normal plasma bicarbonate concentration. This
suggestion was based on the observation that when alkali
therapy was discontinued in patients with minimal or no
bicarbonaturia, the pH of the urine did not decrease
promptly to appropriately low values as acidosis recurred.
Rather, just as in patients with prototypic Type 2 RTA, the
pH of the urine remained inappropriately high over a
broad range of progressively subnormal plasma bicarbonate
concentrations, and became appropriately low only after
substantial reductions of plasma bicarbonate concentration.
It was suggested that the "delay" in urinary acidification
reflected a less severe form of the disturbance that results in
frank bicarbonate wasting in some patients.
In several reported patients with chronic renal failure,
the magnitude of reduction of at normal plasma
bicarbonate concentrations has been sufficiently large (IS
to 35%) to implicate the acidification process of the proxi-
mal nephron [76, 100, 105]. Conceivably, reductions of
THc0 of less than 15 % reflect more modest impairment
of proximal tubular function. Using micropuncture me-
thods, Lubowitz et al [108] have found substantial re-
ductions of fractional bicarbonate reabsorption in the
proximal convulted tubules of surface nephrons in rats with
experimentally-induced chronic renal failure.
The cause of the impairment of renal bicarbonate re-
absorption in chronic renal failure has not been defined.
Schwartz et al [96] and Relman [107] have attributed it to
damage to the renal tubule; they suggested that chronic
renal disease reduces the activity of renal carbonic an-
hydrase, but regarded the evidence in support of this
possibility as unconvincing. Morrin et al [109], Seldin,
Carter, and Rector [101], and Lubowitz et al [108] con-
sider the impairment in bicarbonate reabsorption a conse-
quence of the reduction in number of functioning nephrons
and therefore the result of the same physiological factors
that reduce renal sodium reabsorption in chronic renal
failure: increased filtered load per nephron of poorly re-
absorbable solute, and expanded extracellular fluid volume.
According to their formulation, impaired bicarbonate re-
absorption is an undesirable consequence of the adaptive
response of the kidney that re-establishes sodium balance
in the face of reduced glomerular filtration.
The impairment of renal bicarbonate reabsorption in
chronic renal failure could also be due in part to hyper-
parathyroidism, another predictable consequence of a
reduction in number of functioning nephrons [110, 111].
If increased circulating levels of parathyroid hormone can
cause a reduction of renal bicarbonate reabsorption in
patients who do not have primary renal disease (e. g., nor-
mal subjects [64], patients with malabsorption syndrome
[76]), as well as in those who have a primary disease of the
renal tubules (e. g., patients with cystinosis [66], poly-
cystic kidneys [76]), it seems entirely possible that increased
circulating levels of parathyroid hormone might also cause
a reduction of renal bicarbonate reabsorption in patients
with the common forms of chronic renal failure (e. g.,
patients with chronic glomerulonephritis). To investigate
this possibility we measured renal bicarbonate reabsorption
before and after suppressing parathyroid hormone secretion
(intravenous calcium administration) in a uremic patient
with biopsy-proved glomerulonephritis who had substantial
bicarbonaturia during alkali therapy. During the initial
study, when the serum calcium concentration was low and
the serum parathyroid hormone concentration was high,
35.2% of the filtered load of bicarbonate was excreted in
the urine at normal plasma bicarbonate concentrations
(Table 4: C0/C1, 100=35.3+2.7%). During the
second study, after intravenous administration of calcium
gluconate (25 mg/kg body wt) over a five-hour period
during the previous night, only 11.2% of the filtered bi-
carbonate load was excreted at similar plasma bicarbonate
concentrations (Table 4: C0/C1. 100= I 1.2+4.4%).
336 Morris et a!
Table 4. Effect of intravenous administration of calcium gluconate on renal bicarbonate reabsorption at normal plasma bicarbonate
concentrations in a patient with advanced renal failure
Serum
"HCO1 U110VJC CJO/CIfl C1
Ca PTH > 100
mg/100 ml ngEq/ml mmoles/liter pmoles/ml % mmoles/ mi/mm
100 ml GFR
V/C1,,
Day
1
(9—11 AM)
8.3 75, 87b 25.0 8.82 35.3 1.61 4.9
±0.1
41.8
9 7:00 pm—12 :00 midnight: 5% calcium gluconate i. v. to deliver 25 mg calcium/kg body wt
10
(9—11 AM)
10.5 1,3, 1.2" 26.5 5.70 21.5 2.08 3.0 41.4
P <0.01 <0.01 <0.01 <0.01 <0.01 NS
Abbreviations: PTH, parathyroid hormone; HCO1' plasma bicarbonate concentration; NS, not significant.
a Except for the values of serum PTH concentration, each value is the mean one SD of three or more successive values.
Serum levels of parathyroid hormone measured by Dr. Betty Roof with radioimmunoassay.
The increase in renal bicarbonate reabsorption accompanied
a reduction of the concentration of serum parathyroid hor-
mone to a nearly normal level (Table 4). Accordingly, in
this patient, two-thirds or more of the reduction of renal
bicarbonate reabsorption may have been due to hyperpara-
thyroidism. Conceivably, the reduction of renal bicarbonate
reabsorption in chronic renal failure is due largely to hyper-
parathyroidism; in some patients normalization of bicar-
bonate reabsorption may require prolonged normalization
of the serum parathyroid hormone concentration.
Since parathyroid hormone characteristically suppresses
proximal sodium reabsorption [711 as well as renal bicar-
bonate reabsorption, and since hyperparathyroidism is a
predictable consequence of a reduction in number of
functioning nephrons [110, 1111, it is conceivable that in
chronic renal failure increased circulating levels of para-
thyroid hormone mediate (at least in part) both the adap-
tive renal response that re-establishes sodium balance and
the impairment of renal bicarbonate reabsorption. Further,
by sustaining delivery to the distal nephron of an increased
fraction of the filtered load of sodium and bicarbonate, and
thereby stimulating secretion of potassium in the distal
nephron, hyperparathyroidism in chronic renal failure may
indirectly contribute to the establishment of potassium
balance at normal serum potassium concentrations.
Urinary Ammonium Excretion. The rate of excretion of
urinary ammonium is markedly reduced in patients with
chronic renal failure, despite the presence of sustained
metabolic acidosis [97, 1121. Because the urine is usually
appropriately acidic, most workers have attributed the
reduction of ammonium excretion to diminished production
of ammonia by the kidney rather than to a limitation of its
diffusion into the tubular lumen [93, 101, 107]. The obser-
vation that the reduction in urinary ammonium excretion is
proportional to the reduction in glomerular filtration rate
[11, 113] is consistent with the general view that impaired
ammonium excretion in chronic renal disease results from a
reduction in number of nephrons.
Hyperchloremic acidosis in chronic renal failure. Some
patients with chronic renal failure become acidotic before
impairment of glomerular filtration becomes marked (i. e.,
when GFR is 25 to 30 mI/mm). Such patients are likely
to have renal diseases not associated with primary patho-
logical process in the glomeruli (e. g., chronic pyelone-
phritis, phenacetin nephritis, polycystic kidneys, interstitial
nephritis) and their acidosis is likely to be associated with
hyperchloremia, hyperkalemia, and an acidic urine [114—
116]. The pathogenesis of acidosis in such cases has not been
investigated systematically. In one patient with azotemia
and hyperchloremic acidosis, Seldin et al [101] demon-
strated that renal bicarbonate reabsorption at normal plasma
bicarbonate concentrations was essentially complete. They
postulated that in such cases the number of functioning
nephrons was sufficiently reduced to markedly limit
ammonium excretion and thus cause acidosis, but that the
glomerular filtration rate per residual nephron was so
unusually large that overall glomerular filtration rate was
not markedly reduced and large amounts of unmeasured
anions were not retained. Hyperchloremia was considered
to be a consequence of physiological compensatory pro-
cesses similar to those that increase renal chloride and so-
dium reabsorption in response to acidosis and reduced
Na-H exchange in patients with RTA. Alternatively,
renal ammonia production could be disproportionately
reduced relative to glomerular filtration because of dis-
proportionate damage to the renal tubules. In either case,
the occurrence of hyperkalemia might not be surprising:
in the former because of an unusually low ratio of poorly-
reabsorbable anions to chloride in the distal nephron, in the
latter because of damage to the distal nephron.
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